15/02/2026
If you’ve fallen into the trap of believing the conspiracies, clickbait and “skinny jab” hysteria online about GLP-1 meds… you NEED to listen to this podcast episode.
🎧 What’s The Difference? (Woolies Food Podcast) — the Ozempic / GLP-1 episode is one of the most sensible, science-based conversations I’ve heard in a long time.
Here’s what people are getting wrong:
✨ GLP-1s are not “new”
GLP-1 was discovered in the 1980s, with human research building through the 1990s.
The first GLP-1 medication was approved in 2005 (for Type 2 diabetes) — and Ozempic (semaglutide) was approved in 2017.
✨ They weren’t created for weight loss
They were originally developed for Type 2 diabetes — weight loss was a (very helpful) side effect.
✨ They’re not “cheating”
They’re peptide-based medicines that mimic a hormone your body already uses.
This is healthcare, not a moral test.
✨ They’re being used for WAY more than weight
We’re talking blood sugar, insulin resistance, heart risk, fatty liver… and yes — emerging research around binge eating and addictive behaviours too.
✨ For many Type 2 diabetics, they’re becoming a preferred option before insulin
Not because insulin is bad — but because GLP-1s can treat the underlying metabolic dysfunction with added benefits.
If you’ve ever judged someone for using GLP-1s… or felt ashamed for needing them… this episode will reset your brain in the best way.
Go listen. Then come back and tell me what part finally brought you back to science. 👀
Podcast Episode · What’s the Difference? A Woolies Food Podcast · 04/02/2026 · 52m